The company plans to establish a biologics hub at its Basel, Switzerland campus
Biotechnology | 14/09/2022 | By Sudeep Soparkar
Astellas will invest approximately $70 million to create the new state-of-the-art facility, which will provide lab and co-working spaces to accommodate future growth
Biotechnology | 22/07/2022 | By Sudeep Soparkar | 109
Supports capability built-up in microbial quality control in Pharma, and biopharma industry Merck invests €200,000 in the infrastructure of the new lab at Jigani
Biotechnology | 21/07/2022 | By Sudeep Soparkar | 183
The ~94,000 square-foot facility will house new laboratories to support Selexis’ unique technical cell line workflows and KBI’s process development and cGMP manufacturing
Biotechnology | 11/07/2022 | By Sudeep Soparkar | 179
Oncimmune Holdings announces the signing of two new ImmunoINSIGHTS commercial contracts.
Biotechnology | 15/04/2022 | By Sudeep Soparkar | 117
Moderna and IAVI, a nonprofit scientific research organization, are teaming up to use mRNA to develop new therapies for a range of diseases like HIV / AIDS, Tuberculosis, anti-microbial-resistant enteric infection and COVID-19.
Biotechnology | 12/04/2022 | By Sudeep Soparkar
CEPI, the Coalition for Epidemic Preparedness Innovations, and NEC Corporation declared the most recent subsidizing grant under its US$ 200 million program to propel the improvement of antibodies that give wide assurance against SARS-CoV-2 variations and other betacoronaviruses.
Biotechnology | 09/04/2022 | By Sudeep Soparkar
With the rise in dengue cases across the country, the Indian Council of Medical Research (ICMR) has embarked on an initiative aiming to facilitate development of dengue vaccine. Vaccine manufacturer and pharma companies who have developed or have license of tetravalent dengue vaccine candidate and have successfully completed its phase I and phase II
Biotechnology | 07/03/2022 | By Darshana | 123
The US Food and Drug Administration's (FDA) Office of Orphan Products Development (OOPD) has formally granted Orphan Drug Designation (ODD) to Innovent Biologics's fully-human B-Cell Maturation Antigen (BCMA)-targetted Chimeric Antigen Receptor (CAR) T-cell therapy
Biotechnology | 17/02/2022 | By Darshana | 121
Proteon Pharmaceuticals India, a subsidiary of Proteon Pharmaceuticals SA Poland, announced it will focus on the development of bacteriophages as a sustainable alternative to antibiotics in the poultry industry
Biotechnology | 18/10/2021 | By Darshana | 210